Table 1 Characteristics of Studies Included
Reference/Country/Journal (year) | Study Period (year) | Study type | Sample Size (n, y) | Sex ratio (M/F) | Cirrhosis (y/n), or ICGR15 | |||
|---|---|---|---|---|---|---|---|---|
LMLR | OMLR | LMLR | OMLR | LMLR | OMLR | |||
Cho JY/Korea/ Surgery(2015) [23] | 2003–2012 | R | 24 (53.9 ± 12.6) | 19 (60.0 ± 8.9) | 17/7 | 16/3 | 10/24 ICG 8.2 ± 7.3 | N/A ICG 6.4 ± 4.2 |
Xiao L/China/Surg Endosc (2015) [24] | 2010–2012 | RM | 41 (52.07 ± 11.62) | 86 (50.28 ± 11.89) | 34/7 | 77/9 | 33/41 | 72/86 |
Komatsu S/France/Surg Endosc (2016) [25] | 2000–2014 | RM | 38 (61.5 ± 12.2) | 38 (61.7 ± 16.1) | 34/4 | 33/5 | 31/7 | 28/10 |
Zhang Y/China/Surg Laparosc Endosc Percutan Tech (2016) [26] | 2012–2014 | RM | 20 (47 ± 8.5) | 25 (52 ± 10.5) | 12/8 | 15/10 | 20/0 | 25/0 |
Chen JH/China/Medicine (2017) [27] | 2015–2016 | RM | 126 (51, 21–76) | 133 (51, 12–74) | 93/33 | 108/25 | ICGR15 4.8 ± 3.8 | ICGR15 4.3 ± 4.8 |
Yoon YI/Korea/Ann Surg (2017) [28] | 2007–2015 | RM | 37 (55.19 ± 7.12) | 115 (58.37 ± 9.89) | 26/11 | 93/22 | ICGR15 11.6 ± 4.72 | ICGR15 13.67 ± 5.51 |
Guro H/Korea/Surg Oncol (2018) [29] | 2004–2015 | RM | 67 (57.7 ± 11.1) | 110 (59.11 ± 12.3) | 49/18 | 93/17 | ICGR15 9.1 ± 8.3 | ICGR15 9.5 ± 5.9 |
Rhu J/Korea/World J Surg (2018) [30] | 2009–2016 | RM | 58 (58.2 ± 8.8) | 133 (57.9 ± 9.7) | 46/12 | 114/19 | ICGR15 11.7 ± 5.4 | ICGR15 11.0 ± 4.0 |
Xu H/China/Surg Endosc (2018) [31] | 2015–2017 | RM | 36 (53.5 ± 11.0) | 67 (49.0 ± 13) | 30/6 | 61/6 | ICGR15 4.8 ± 2.2 | ICGR15 4.9 ± 2.1 |